Study to compare the effects of AZD9496 vs Fulvestrant in breast cancer.

Trial Identifier: D6090C00002
Sponsor: AstraZeneca
NCTID:: NCT03236974
Start Date: October 2017
Primary Completion Date: February 2019
Study Completion Date: February 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations